Patents by Inventor Yvonne Marie Angell

Yvonne Marie Angell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMPROVED ANTI-SENESCENCE COMPOUNDS AND USES THEREOF
    Publication number: 20230090099
    Abstract: The present invention relates to improved compounds for use in the treatment of diseases or conditions where the removal of senescent cells, scarred cells, and/or cancerous cells is beneficial, for example cancer. The invention also relates to methods of treating an individual suffering, or suspected of suffering, from a disease or condition wherein the removal of senescent cells, scarred cells, and/or cancerous cells is beneficial.
    Type: Application
    Filed: February 22, 2021
    Publication date: March 23, 2023
    Inventors: Peterus Leonardus Josephus DE KEIZER, Michael TEIFEL, Tobias MADL, Benjamin Michel Rene BOURGEOIS, Emil SPREITZER, Yvonne Marie ANGELL, Marjolein Petronella BAAR
  • Myosin Derived Peptides and Related Compounds with Anticoagulant Activities
    Publication number: 20220340629
    Abstract: The present invention provides myosin derived peptides, variants and derivative compounds that are anti-coagulant. Also provided in the invention are antibodies that specifically target the peptides or epitopes presented thereon. Further provided in the invention are methods directed to using the anti-coagulant compounds described herein in therapeutic applications, e.g., inhibiting myosin-supported prothrombin activation to reduce the risk of acute trauma coagulopathy in post-trauma patients or inhibiting cardiac myosin-supported prothrombin activation to reduce the risk of coronary thrombosis.
    Type: Application
    Filed: May 25, 2022
    Publication date: October 27, 2022
    Inventors: John H. Griffin, Hiroshi Deguchi, Weijun Shen, Sam Lear, Elsa Pflimlin, Yvonne Marie Angell, Mike Lizarzaburu